Ads
related to: what are indications of biaxin action therapy for asthma and bronchitis- Dosing Information
HCPs: See The Dosing Information Of
This Once-Daily Asthma Inhaler.
- Adverse Reactions
Learn About The Adverse Reactions
Of This Daily Asthma Treatment.
- Formulary Coverage
See If Your Patients Are Covered
With This Daily Asthma Treatment.
- Samples & Savings
Request Samples For Your Practice
Daily Triple Therapy Asthma Option.
- Dosing Information
Search results
Results From The WOW.Com Content Network
Clarithromycin, sold under the brand name Biaxin among others, is an antibiotic used to treat various bacterial infections. [3] This includes strep throat, pneumonia, skin infections, H. pylori infection, and Lyme disease, among others. [3] Clarithromycin can be taken by mouth as a tablet or liquid or can be infused intravenously. [3]
This inhibits the synthesis of pro-inflammatory factors that induce asthma attacks and exacerbations, achieving anti-inflammatory effects. [19] For asthma maintenance therapy, methylxanthines are taken orally. [2] Therapeutic drug monitoring is required for patients on methylxanthines as the therapeutic range is narrow.
Benzonatate is a prescription non-opioid alternative for the symptomatic relief of cough.[7] [9] It has been found to improve cough associated with a variety of respiratory conditions including asthma, bronchitis, pneumonia, tuberculosis, pneumothorax, opioid-resistant cough in lung cancer, and emphysema.
While acute bronchitis often does not require antibiotic therapy, antibiotics can be given to patients with acute exacerbations of chronic bronchitis. [21] The indications for treatment are increased dyspnoea, and an increase in the volume or purulence of the sputum. [22]
With the exception of formoterol, LABAs are not recommended for the treatment of acute asthma exacerbations because of their slower onset of action compared to salbutamol. Their long duration of action is due to the addition of a long lipophilic side-chain that binds to an exosite on adrenergic receptors.
The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.